Healthcare
FNArena Windows (Sectors)
Introduction to FNArena Windows
FNArena Windows offers subscribers the option to investigate ASX-listed stocks against their peers. FNArena developed its own sector methodology which in our view overcomes many flaws and disadvantages connected with GICS sectors. Our system starts with three broad sector labels: COMMODITIES, FINANCIAL SERVICES and INDUSTRIALS. From here onwards subscribers can explore further through gradually narrowing branches. This is not investment advice, but simply another window on the Australian Stock Exchange to provide better insight and to assist FNArena subscribers while conducting their own market analysis.
Latest Stories
Michael Gable of Fairmont Equities observes CSL shares are breaking through a ceiling that has held for four years, suggesting major upside potential
10:30 AM
The New Criterion’s Tim Boreham shines the light on family-run dental products manufacturer SDI (Formerly Southern Dental Industries)
Jul 19 2024
| ASX CODE | COMPANY NAME | LAST PRICE | 52WK HIGH | 52WK LOW | P/E | CONSENSUS TARGET |
|---|---|---|---|---|---|---|
| 4DX | 4DMEDICAL LIMITED | $0.52 | $1.10 | $0.45 |
$1.15 |
|
| ACL | AUSTRALIAN CLINICAL LABS LIMITED | $2.46 | $3.36 | $2.15 | 16.3 |
$3.033 |
| ALC | ALCIDION GROUP LIMITED | $0.05 | $0.13 | $0.04 |
$0.05 |
|
| APM | APM HUMAN SERVICES INTERNATIONAL LIMITED | $1.40 | $2.24 | $0.68 | 15.0 |
$1.433 |
| ARX | AROA BIOSURGERY LIMITED | $0.61 | $0.96 | $0.48 | 77.7 |
$0.975 |
| AVH | AVITA MEDICAL INC | $2.86 | $xx.xx | $xx.xx | xx.x | xx.xx |
| BIO | AVITA MEDICAL INC | $0.62 | $xx.xx | $xx.xx | xx.x | xx.xx |
| BMT | BEAMTREE HOLDINGS LIMITED | $0.22 | $xx.xx | $xx.xx | xx.x | xx.xx |
| CAJ | CAPITOL HEALTH LIMITED | $0.31 | $xx.xx | $xx.xx | xx.x | xx.xx |
| CAT | CATAPULT GROUP INTERNATIONAL LIMITED | $2.02 | $xx.xx | $xx.xx | xx.x | xx.xx |
| COH | COCHLEAR LIMITED | $328.44 | $xx.xx | $xx.xx | xx.x | xx.xx |
| CSL | CSL LIMITED | $309.18 | $xx.xx | $xx.xx | xx.x | xx.xx |
| CU6 | CSL LIMITED | $6.14 | $xx.xx | $xx.xx | xx.x | xx.xx |
| CUV | CLINUVEL PHARMACEUTICALS LIMITED | $15.25 | $xx.xx | $xx.xx | xx.x | xx.xx |
| CYC | CYCLOPHARM LIMITED | $1.64 | $xx.xx | $xx.xx | xx.x | xx.xx |
| DOC | DOCTOR CARE ANYWHERE GROUP PLC | $0.07 | $xx.xx | $xx.xx | xx.x | xx.xx |
| EBO | EBOS GROUP LIMITED | $31.50 | $xx.xx | $xx.xx | xx.x | xx.xx |
| EBR | EBR SYSTEMS INC | $1.11 | $xx.xx | $xx.xx | xx.x | xx.xx |
| FPH | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED | $28.68 | $xx.xx | $xx.xx | xx.x | xx.xx |
| GSS | GENETIC SIGNATURES LIMITED | $0.76 | $xx.xx | $xx.xx | xx.x | xx.xx |
| HLS | HEALIUS LIMITED | $1.48 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IDX | INTEGRAL DIAGNOSTICS LIMITED | $2.50 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IME | IMEXHS LIMITED | $0.48 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IMM | IMMUTEP LIMITED | $0.30 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IMR | IMRICOR MEDICAL SYSTEMS INC | $0.58 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IMU | IMRICOR MEDICAL SYSTEMS INC | $0.06 | $xx.xx | $xx.xx | xx.x | xx.xx |
| INA | INGENIA COMMUNITIES GROUP | $5.06 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IPD | IMPEDIMED LIMITED | $0.07 | $xx.xx | $xx.xx | xx.x | xx.xx |
| LIC | LIFESTYLE COMMUNITIES LIMITED | $9.60 | $xx.xx | $xx.xx | xx.x | xx.xx |
| M7T | MACH7 TECHNOLOGIES LIMITED | $0.57 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MAP | MICROBA LIFE SCIENCES LIMITED | $0.17 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MDR | MEDADVISOR LIMITED | $0.55 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MPL | MEDIBANK PRIVATE LIMITED | $3.80 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MSB | MESOBLAST LIMITED | $1.16 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MVF | MONASH IVF GROUP LIMITED | $1.29 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MX1 | MICRO-X LIMITED | $0.08 | $xx.xx | $xx.xx | xx.x | xx.xx |
| NAN | NANOSONICS LIMITED | $3.10 | $xx.xx | $xx.xx | xx.x | xx.xx |
| NEU | NEUREN PHARMACEUTICALS LIMITED | $20.55 | $xx.xx | $xx.xx | xx.x | xx.xx |
| NHF | NIB HOLDINGS LIMITED | $7.12 | $xx.xx | $xx.xx | xx.x | xx.xx |
| PAR | PARADIGM BIOPHARMACEUTICALS LIMITED | $0.30 | $xx.xx | $xx.xx | xx.x | xx.xx |
| PER | PERCHERON THERAPEUTICS LIMITED | $0.08 | $xx.xx | $xx.xx | xx.x | xx.xx |
| PGC | PARAGON CARE LIMITED | $0.45 | $xx.xx | $xx.xx | xx.x | xx.xx |
| PME | PRO MEDICUS LIMITED | $131.33 | $xx.xx | $xx.xx | xx.x | xx.xx |
| PNV | POLYNOVO LIMITED | $2.41 | $xx.xx | $xx.xx | xx.x | xx.xx |
| PSQ | PACIFIC SMILES GROUP LIMITED | $1.82 | $xx.xx | $xx.xx | xx.x | xx.xx |
| PYC | PYC THERAPEUTICS LIMITED | $0.11 | $xx.xx | $xx.xx | xx.x | xx.xx |
| REG | REGIS HEALTHCARE LIMITED | $4.15 | $xx.xx | $xx.xx | xx.x | xx.xx |
| RHC | RAMSAY HEALTH CARE LIMITED | $46.86 | $xx.xx | $xx.xx | xx.x | xx.xx |
| RMD | RESMED INC | $30.69 | $xx.xx | $xx.xx | xx.x | xx.xx |
| SHL | SONIC HEALTHCARE LIMITED | $26.59 | $xx.xx | $xx.xx | xx.x | xx.xx |
| TLX | TELIX PHARMACEUTICALS LIMITED | $19.63 | $xx.xx | $xx.xx | xx.x | xx.xx |
| TRJ | TRAJAN GROUP HOLDINGS LIMITED | $0.97 | $xx.xx | $xx.xx | xx.x | xx.xx |
Previous Stories
‘Defensive’ Pharmaceutical Wholesalers In Focus
Jul 18 2024
New research on the Pharmaceutical Wholesaling sector identifies three stocks with long-term defensive growth within an improving government funding framework
Twists And Turns Of Telix And Australian Biotech
Jul 10 2024
In the wake of Telix Pharmaceuticals’ non-IPO on the Nasdaq, FNArena shines a light on the company’s fortunes and that of Australian biotech and cancer research generally
Dr Boreham’s Crucible: Radiopharm Theranostics
Jul 03 2024
The New Criterion’s Tim Boreham explains the how and why behind Radiopharm Theranostics’ latest capital raising
Building The No 3 Diagnostic Imaging Player
Jun 19 2024
Brokers highlight deregulation and scale benefits from the potential merger of Integral Diagnostics and Capitol Health
Dr Boreham’s Crucible: Island Therapeutics
Jun 17 2024
The next twelve months could be exciting for Dengue fever solutions seeker Island Therapeutics, the New Criterion’s Tim Boreham reports
The Monday Report – 17 June 2024
Jun 17 2024
Wrap of events affecting the market on Friday night and the weekend and a preview of the week ahead
Dr Boreham’s Crucible: Amplia Therapeutics
Jun 05 2024
Amplia Therapeutics is in pursuit of a cancer drug for pancreatic cancer and possibly other indications including ovarian cancer, the New Criterion’s Tim Boreham reports
Is The Long Wait For CSL About To End?
May 30 2024
The Chartist reports it looks like CSL shares might be ready to leave the past four-year pause in the past
Dr Boreham’s Crucible: Blinklab
May 20 2024
Recently ASX-listed Blinklab claims the world’s best mobile phone app for detecting autism, the New Criterion’s Tim Boreham reports
Dr Boreham’s Crucible: Invion
May 13 2024
As per the New Criterion’s Tim Boreham, Invion is an old company on a new mission
Latest News
| 1 |
Treasure Chest: JB Hi-Fi11:33 AM - Treasure Chest |
| 2 |
CSL Shares Breaking Free10:30 AM - Technicals |
| 3 |
Weekly Update On LICs & LITs – 23-Jul-202410:00 AM - Weekly Reports |
| 4 |
The Overnight Report: Bulls Back In Charge8:49 AM - Daily Market Reports |
| 5 |
Today’s Financial Calendar – 23-07-20248:15 AM - Daily Market Reports |